ResearcherChinese Academy of SciencesActive in the last 2 years

Hui Zeng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7456-6061; OpenAlex author ID A5011433487. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Harnessing dendritic cells for pancreatic cancer immunotherapy: a novel promising approach. Co-author DOI 10.1002/mco2.70066 ↗
A pectin-like polysaccharide from Polygala tenuifolia inhibits pancreatic cancer cell growth in vitro and in vivo by inducing apoptosis and suppressing autopha… First author DOI 10.1016/j.ijbiomac.2020.06.054 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xinghua Long · 1 shared paper, 2025 · strength 0.42
- Paper Harnessing dendritic cells for pancreatic cancer immunotherapy: a novel promising approach. DOI 10.1002/mco2.70066 ↗
Youcheng Bian · 1 shared paper, 2020 · strength 0.13
- Paper A pectin-like polysaccharide from Polygala tenuifolia inhibits pancreatic cancer cell growth in vitro and in vivo by in… DOI 10.1016/j.ijbiomac.2020.06.054 ↗
Hong Tao · 1 shared paper, 2020 · strength 0.13
- Paper A pectin-like polysaccharide from Polygala tenuifolia inhibits pancreatic cancer cell growth in vitro and in vivo by in… DOI 10.1016/j.ijbiomac.2020.06.054 ↗
Kan Ding · 1 shared paper, 2020 · strength 0.13
- Paper A pectin-like polysaccharide from Polygala tenuifolia inhibits pancreatic cancer cell growth in vitro and in vivo by in… DOI 10.1016/j.ijbiomac.2020.06.054 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.